Substance / Medication

Leuprorelin

Overview

Active Ingredient
leuprolide
RxNorm CUI
42375

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

43 trials linked to this intervention

43
Total Trials
39
Recruiting
1
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Therapeutic impact of leuprorelin acetate on spinal and bulbar muscular atrophy: pre- and post-marketing observational study.
Hashizume Atsushi, Hanazawa Ryoichi, Yamada Shinichiro et al. · J Neurol · 2025
PMID: 41258507Observational
Efficacy of leuprorelin in spinal and bulbar muscular atrophy: a 3-year observational study.
Kang Min-Gu, Kang Minsung, Cho Hee-Jin et al. · Neurol Sci · 2024
PMID: 38400888Observational
Effect of leuprorelin in bulbar function of spinal and bulbar muscular atrophy patients: observational study for 1 year.
Kang Min-Gu, Gwak Dae-Won, Cho Hee-Jin et al. · J Neurol · 2021
PMID: 33675422Observational
Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Compared With Leuprorelin Injections for Uterine Leiomyomas: A Randomized Controlled Trial.
Osuga Yutaka, Enya Kazuaki, Kudou Kentarou et al. · Obstet Gynecol · 2019
PMID: 30741797Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Leuprorelin (substance)
SNOMED CT
397198002
UMLS CUI
C0085272
RxNorm CUI
42375

Clinical Data

This intervention maps to 12 entities in the Healos knowledge graph.

8
Conditions
1
Biomarkers
2
Specialists
0
Symptoms
43
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.